68 related articles for article (PubMed ID: 3555181)
1. [Serum fructosamine in the monitoring of insulin therapy in the diabetic child].
Bellanné C; Georges P; Bougnières PF; Chaussain JL
Ann Biol Clin (Paris); 1987; 45(1):85-6. PubMed ID: 3555181
[No Abstract] [Full Text] [Related]
2. [Measurement of plasma fructosamine in children with insulin-dependent diabetes mellitus].
Hirai M; Kobayashi N; Shimojo N; Naka K; Yoshikawa C; Okuda K; Aono S
Rinsho Byori; 1988 Aug; 36(8):939-42. PubMed ID: 3071634
[No Abstract] [Full Text] [Related]
3. [Longitudinal study of the concentration of serum fructosamine in diabetic patients (type 1 and type 2)].
Fernandes F; Neto I; Pinto C; Parreira J; André O; Lisboa P; Azevedo M; Manso C
Acta Med Port; 1986; 7(5-6):189-91. PubMed ID: 3630769
[No Abstract] [Full Text] [Related]
4. Fructosamine level in blood serum of patients with diabetes mellitus type I (IDDM) in different stages of the disease.
Tuszkiewicz-Misztal E; Lozowska A
Mater Med Pol; 1988; 20(4):258-61. PubMed ID: 3249545
[No Abstract] [Full Text] [Related]
5. [N-acetyl-beta-D-glucosaminidase activity in relation to blood glucose, serum fructosamine and type I diabetic nephropathy].
Pinto C; Fernandes F; Marques C; Silva A; Azevedo M; Lisboa P; Manso C
Acta Med Port; 1985; 6(3-4):97-102. PubMed ID: 4025000
[No Abstract] [Full Text] [Related]
6. [Should the assay of fructosamine be part of the elements of diabetic monitoring?].
Maugendre D; Dezier JF; le Treut A; Allannic H
Diabete Metab; 1990; 16(1):55-8. PubMed ID: 2185057
[No Abstract] [Full Text] [Related]
7. Goals and assessment of diabetic control.
Scott DJ; Cooper GJ
N Z Med J; 1985 Jul; 98(782):536-8. PubMed ID: 3897925
[No Abstract] [Full Text] [Related]
8. [Serum fructosamine studies in pediatric diabetology].
Acsai L; Szoboszlay I; Petheö I
Orv Hetil; 1989 Oct; 130(40):2147-50. PubMed ID: 2694056
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of fructosamine determination in short-term monitoring of metabolic control in children with insulin-dependent diabetes mellitus at onset].
De Campo C; Monciotti C; Grossi F; Bertotti A; Pocecco M
Pediatr Med Chir; 1987; 9(5):583-4. PubMed ID: 3327054
[TBL] [Abstract][Full Text] [Related]
10. Influence of protein and albumin levels on serum fructosamine concentration in a diabetic patient with multiple myeloma.
Comtois R; Couturier M; Ammann H
Clin Biochem; 1994 Oct; 27(5):421-3. PubMed ID: 7867222
[No Abstract] [Full Text] [Related]
11. Fructosamine and diabetes.
Lim HS
Singapore Med J; 1988 Dec; 29(6):541, 543. PubMed ID: 3252460
[No Abstract] [Full Text] [Related]
12. Current state of metabolic control achieved in a New Zealand diabetes clinic.
Dunn PJ
N Z Med J; 1996 Mar; 109(1018):98-101. PubMed ID: 8606845
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Roche fructosamine test: use for diabetic patient monitoring.
Glikmanas G; Sarmini H; Bigorie B; Haioun B; Gouget B; Truchaud A
Clin Biochem; 1988 Oct; 21(5):319-21. PubMed ID: 3233743
[TBL] [Abstract][Full Text] [Related]
14. [Relation between retinopathy and glucose compensation in diabetic children and adolescents].
Filous A; Rychnová J; Vavrinec J
Cesk Pediatr; 1993 Sep; 48(9):526-9. PubMed ID: 8252651
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of the determination of serum fructosamine and albumin in children with diabetes mellitus].
Vakhrusheva LL; Kniazev IuA; Sergeeva NA; Martynova MI; Chesnokova TT
Probl Endokrinol (Mosk); 1989; 35(1):22-5. PubMed ID: 2717569
[TBL] [Abstract][Full Text] [Related]
16. [Markedly elevated serum fructosamine in a non-diabetic patient with IgA-kappa type multiple myeloma].
Nakamura F; Kaimori M; Takaya H; Fujita K; Suzuki N; Sakurabayashi I; Yoshioka N
Rinsho Byori; 1996 Jan; 44(1):85-9. PubMed ID: 8691646
[TBL] [Abstract][Full Text] [Related]
17. [Fructosamine levels as an indicator of the glycosylation of serum proteins in diabetes mellitus type 1: clinical significance].
Podgórski G; Czech A; Tatoń J; Laz R
Pol Tyg Lek; 1987 Dec; 42(50):1581-4. PubMed ID: 3452802
[No Abstract] [Full Text] [Related]
18. Serum fructosamine concentration as measure of blood glucose control in insulin dependent diabetes.
Luqman W; Abdella N; Moro M
Br Med J (Clin Res Ed); 1985 Apr; 290(6474):1075-6. PubMed ID: 3921112
[No Abstract] [Full Text] [Related]
19. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk.
Schiaffini R; Ciampalini P; Fierabracci A; Spera S; Borrelli P; Bottazzo GF; Crinò A
Diabetes Metab Res Rev; 2002; 18(4):324-9. PubMed ID: 12203948
[TBL] [Abstract][Full Text] [Related]
20. [Functional insulin therapy in the type 1 diabetic].
Grimm JJ; Hegar K; Berger W
Journ Annu Diabetol Hotel Dieu; 2000; ():145-54. PubMed ID: 10932877
[No Abstract] [Full Text] [Related]
[Next] [New Search]
